Market Analysis

All Reports

Browse our comprehensive collection of market intelligence reports.

Healthcare|March 2020

Pertonitis Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments

Pertonitis Pipeline Analysis 2018 – Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Developments.Peritonitis Pipeline Analysis report covers 12 drugs currently in different phases of development. Perironitis is inflammation of the peritoneum. Peritoneum is the tissue lining the inner wall of the abdomen and internal organs such as kidneys and liver. It

Healthcare|March 2020

Epidermolysis Bullosa (EB) Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments

Epidermolysis Bullosa (EB) Pipeline Analysis 2018 – Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Developments.Epidermolysis Bullosa Pipeline Analysis report covers 19 drugs currently in different phases of development. Epidermolysis bullosa is a group of rare inherited diseases characterised by appearance of bl

Healthcare|March 2020

Acute Radiation Syndrome (ARS) Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments

Acute Radiation Syndrome (ARS) Pipeline Analysis 2018 – Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Developments.Acute radiation Syndrome Pipeline Analysis report covers 28 drugs currently in different phases of development. Acute Radiation Syndrome also known as radiation toxicity or radiation sickness is an acute illness which occurs after irradi

Healthcare|March 2020

Bronchiectasis Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments

Bronchiectasis Pipeline Analysis report covers 12 drugs currently in different phases of development. Bronchiectasis is a chronic disease characterised by thickening and inflammation of the walls of the bronchi along with the damaged air passages. These damaged air passages allow bacteria and mucus to build up in the lungs leading to frequent infections and blockage of the airways. Symptoms include persistent cough, production of large amounts of sputum and mucus, trapped

Healthcare|March 2020

MRSA Infections Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Developments

MRSA Infections Pipeline Analysis report covers more than 10 drugs currently in different phases of development. MRSA Infections are also known as Methicillin-resistant Staphylococcus Aureus (MRSA) infection caused by a type of Staphylococcus or staph bacteria which is resistant to various antibiotics. These bacteria live naturally in the nose and on the skin and are innocuous till they multiply in an uncontrolled manner causing an MRSA infection. The infections a

Healthcare|March 2020

Synovitis Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Developments

Synovitis Pipeline Analysis report covers more than 10 drugs currently in different phases of development. Synovitis is a diseased condition which results due to the inflammation of the tissue lining a joint. It is caused due to the association with specific diseases like arthritis or gout or may be due to the overuse or trauma as well. Symptoms include redness, swelling, pain of the joints with motion and the treatment includes rest, ice, immobilization and anti-inflammatory drugs. Surg

Healthcare|March 2020

Atypical Hemolytic Uremic Syndrome (aHUS) Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments

Atypical hemolytic uremic syndrome (aHUS) Pipeline Analysis 2018 – Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Developments.Atypical hemolytic uremic syndrome (aHUS) Pipeline Analysis report covers 10 drugs currently in different phases of development. Atypical hemolytic-uremic syndrome is a rare renal disease characterised by abnormal clotting: ha

Healthcare|March 2020

Mucopolysaccharidosis III (Sanfilippo syndrome) Pipeline Analysis 2018 (Q1) - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments

Mucopolysaccharidosis III (Sanfilippo syndrome) Pipeline Analysis 2018 – Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Developments. Mucopolysaccharidosis III (Sanfilippo syndrome) Pipeline Analysis report covers 12 drugs currently in different phases of development. Mucopolysaccharidosis III is a rare inherited autosomal recessive disorder characterised by progressive dementia, aggressive behavior, hyperactivity, seizure

Healthcare|March 2020

Mucopolysaccharidosis I (Hurler Syndrome) Pipeline Analysis 2018 (H1) - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments

Mucopolysaccharidosis I (Hurler Syndrome) Pipeline Analysis 2018 – Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Developments. Mucopolysaccharidosis I (Hurler Syndrome) Pipeline Analysis report covers 11 drugs currently in different phases of development. Hurler Syndrome is an inherited lysosomal storage disease caused by defect in IDUA gene. The defect in the gene results in deficiency of al

Healthcare|March 2020

Becker Muscular Dystrophy Pipeline Analysis 2018 (Q1) - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Developments

Becker Muscular Dystrophy Pipeline Analysis 2018 – Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Developments. Becker Muscular Dystrophy (BMD) Pipeline Analysis report covers 6 drugs currently in different phases of development. Becker muscular dystrophy is an X-linked recessive genetic disorder characterized by progressive weakness and wasting of the skeletal and cardiac muscles and is caused by is caused by a mutation i

Healthcare|March 2020

Duchenne Muscular Dystrophy (DMD) Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Developments

Duchenne Muscular Dystrophy (DMD) Pipeline Analysis 2018 – Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Developments.Duchenne Muscular Dystrophy (DMD) Pipeline Analysis report covers 40 drugs currently in different phases of development. Duchenne Muscular Dystrophy (DMD) is a genetic disorder caused by the absence of a protein known as dystrophin. T

Healthcare|March 2020

IgA Nephropathy Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Developments

IgA Nephropathy Pipeline Analysis report covers 17 drugs currently in different phases of development. IgA Nephropathy is also known as Berger’s disease occurs when there is an accumulation of immunoglobulin A (IgA) in the kidneys. This gives rise to kidney inflammation and may damage the kidney’s ability to filter waste, slowly with time. The disease is asymptomatic in the beginning and can be detected only by routine tests. Presence of protein and red blood cells in the uri